What is the treatment for vertebral artery dissection?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 10, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Vertebral Artery Dissection

The treatment of vertebral artery dissection is primarily conservative, involving anticoagulation with heparin followed by warfarin for 3-6 months, after which antiplatelet therapy may replace anticoagulation once symptoms resolve. 1

Diagnosis

  • CT angiography (CTA), MR angiography (MRA), or catheter-based contrast angiography are the preferred diagnostic modalities for vertebral artery dissection (Class I recommendation) 2
  • Carotid duplex ultrasonography may identify a dissection flap and differential flow in the true and false lumens, but may miss dissections that begin above the angle of the mandible 1
  • Selective catheterization of vertebral arteries may be necessary to delineate collateral filling via the circle of Willis, which guides management 1

Medical Management

Antithrombotic Therapy

  • For symptomatic vertebral artery dissection, antithrombotic therapy is recommended for 3-6 months (Class IIa recommendation) 1, 2
  • Initial treatment options include:
    • Anticoagulation with intravenous heparin followed by warfarin (target INR 2.0-3.0) 1, 2
    • Low molecular weight heparin followed by warfarin 1
    • Antiplatelet therapy with aspirin (81-325 mg daily) or clopidogrel (75 mg daily) 1, 2
  • After the initial 3-6 month period, transition to antiplatelet therapy is recommended 1, 2
  • The CADISS trial found no significant difference between antiplatelet and anticoagulant treatments in preventing recurrent stroke in cervical artery dissection (stroke recurrence was rare in both groups) 3

Blood Pressure Management

  • The safety and effectiveness of pharmacological therapy with beta-adrenergic antagonists, angiotensin inhibitors, or non-dihydropyridine calcium channel antagonists (verapamil or diltiazem) to lower blood pressure and reduce arterial wall stress are not well established (Class IIb recommendation) 1, 2

Invasive Treatment

  • Surgical or endovascular revascularization is reserved for patients with persistent or recurrent symptoms that fail to respond to antithrombotic therapy 1
  • Endovascular options include:
    • Angioplasty and stenting may be considered when ischemic neurological symptoms have not responded to antithrombotic therapy (Class IIb recommendation) 1, 2
    • For dominant vertebral artery dissection, stent-assisted reconstruction can restore vessel lumen integrity 4, 5
    • For non-dominant vertebral artery dissection causing emboli, occlusion with coils may be considered 4
  • Surgical options (rarely performed) include:
    • Direct vertebral artery repair 1
    • Resection with vein graft replacement 1

Prognosis and Follow-up

  • With appropriate antithrombotic treatment, the prognosis is usually favorable 1
  • The annual rate of recurrent stroke, TIA, or death was reported as 8.3% in patients treated with anticoagulants versus 12.4% in those treated with aspirin in one observational study 1
  • More recent data from the CADISS trial suggests the risk of recurrent stroke is much lower than previously reported in observational studies, with only 2% of patients experiencing recurrent stroke 3

Special Considerations

  • Anticoagulation may adversely influence the outcome if subarachnoid hemorrhage occurs due to intracranial extension of the dissection 1
  • For patients with bilateral vertebral artery dissections, treatment decisions should be based on the dominance of the affected vessels and presence of embolic complications 4, 5
  • A high index of suspicion for vertebral artery dissection should be maintained in younger patients with stroke symptoms, as it accounts for 10-15% of ischemic strokes in patients under 45 years 2, 6

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Carotid Artery Dissection Treatment

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Endovascular Treatment of Intracranial Vertebral Artery Dissection.

Journal of neuroendovascular therapy, 2021

Research

Vertebral Artery Dissection.

BMJ case reports, 2024

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.